Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. IKT
IKT logo

IKT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IKT News

INHIBIKASE THERAPEUTICS INC: BOFA GLOBAL RESEARCH STARTS COVERAGE WITH A BUY RATING AND A TARGET PRICE OF $6

Jan 21 2026moomoo

Intuit Shares Rise: 20 Stocks Making Moves in Premarket Trading

Nov 21 2025Benzinga

Inhibikase Therapeutics Enhances Leadership with Timothy Pigot's Appointment as Chief Commercial and Strategy Officer

Aug 19 2025Newsfilter

Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity

Aug 14 2025Newsfilter

Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity

May 14 2025Newsfilter

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Inhibikase Therapeutics, Inc. (NASDAQ: IKT)

May 05 2025PRnewswire

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Apr 14 2025Newsfilter

HC Wainwright & Co. Reiterates Neutral on Inhibikase Therapeuticsto Neutral

Mar 28 2025Benzinga

IKT Events

12/26 16:10
Stocks Fluctuate Near All-Time Highs, S&P 500 Slightly Declines
The post-Christmas session saw stocks fluctuate near all-time highs and the indexes close little changed following a day of thin trading. While the S&P 500 saw a very small daily drop, it still closed with its best week in a month.Get caught up quickly on the top news and calls moving stocks with this recap from The Fly.1. STOCK NEWS:Nvidialicensingand hiring top executives, including its CEO, in deal reported to be worth $20BTargetfacing pressure from activist investor Toms Capital,Biohavenannounced on Christmas Eve that its Phase 2 proof-of-concept study evaluating BHV-7000 for the treatment of major depressive disorderWALL STREET CALLS:Inhibikase Therapeuticswith a Buy at H.C. WainwrightCarter Bankshareswith a Buy at Freedom CapitalMDU Resourceswith a Hold at Freedom CapitalWalmartwith an Outperform at CICC3. AROUND THE WEB:Following the Trump administration's approval of a weapons sale to Taiwan, the Chinese government imposed sanctions on 20 U.S. defense companies and 10 of their executives, with targets including Northrop Grumman (NOC), Boeing'sdefense unit,A federal judge denied Masimo'srequest to block Apple Watchimports as part of its lawsuit over an earlier import ban related to patents covering blood-oxygen sensors,Hyattis developing collaborations with Chinese state-owned companies for joint-venture brands amid a slowdown in the region and an effort to expand outside Greater China to double properties in Asia,JPMorgan Chasein recent months has frozen accounts used by at least two fast-growing stablecoin startups, highlighting the risk that Cryptocurrency transactions pose for banks, which are required to know the people they do business with and the source of their cash,4. MOVERS:Coupanggained afterthe company identified the former employee responsible for the recent data leakNikerose after UBS said its recentfor the companyArcadia Biosciencesfell afterand resumption of its process of evaluating strategic alternativesMakers of wound-care products, including Organogenesis, declined after regional Medicare contractorsand tissue repair productsINDEXES:The Dow fell 0.04%, or 20.19, to 48,710.97, the Nasdaq slipped 0.09%, or 20.21, to 23,593.10, and the S&P 500 declined 0.03%, or 2.11, to 6,929.94.

IKT Monitor News

Inhibikase Therapeutics reaches 20-day high amid sector rotation

Feb 23 2026

IKT Earnings Analysis

No Data

No Data

People Also Watch